Sort
25,944 grants matching “neurodegeneration”
Supplement Request for Emergency Replacement of EPR Amplifier and Acquisition of a Low Volume Resonator for Membrane Proteins
$241,253Glenn L Millhauser · University Of California Santa Cruz · R35 · FY2024 · GM
Molecular neuropathology of TDP-43 proteinopathies
$241,250Edward Byung-Ha Lee · University Of Pennsylvania · R21 · FY2016 · NS
TIP60 and APP in Neuronal Development
$241,141Felice Elefant · Drexel University · R01 · FY2011 · HD
Engineering selective metalloproteinases inhibitors for developing new therapeutics for neurodegenerative diseases
$241,109Maryam Raeeszadeh Sarmazdeh · University Of Nevada Reno · P20 · FY2021 · GM
C9orf72 hexanucleotide repeat expansion caused neurodegeneration in ALS and FTD
$241,108Shuying Sun · Johns Hopkins University · R00 · FY2018 · NS
ADF-Actin Rods in Neurodegenerative Diseases
$241,063Colorado State University-Fort Collins · R01 · FY2004 · NS
ADF-Actin Rods in Neurodegenerative Diseases
$241,063Colorado State University-Fort Collins · R01 · FY2005 · NS
ADF-Actin Rods in Neurodegenerative Diseases
$241,063Colorado State University-Fort Collins · R01 · FY2003 · NS
MECHANISMS OF GLUTAMINE REPEAT NEURODEGENERATION
$241,039University Of Iowa · R01 · FY2000 · NS
Elucidating the molecular mechanisms of spinocerebellar ataxia gene TMEM16K in interorganellar communication
$241,004Yuh Nung Jan · University Of California, San Francisco · R21 · FY2020 · AG
The structural basis of apoE4's role in Alzheimer's Disease
$240,973John Carl Voss · University Of California At Davis · R01 · FY2011 · AG
Mechanisms of protein turnover in apoptosis
$240,895John Robert Nambu · University Of Massachusetts Amherst · R01 · FY2006 · AG
Pre-clinical testing of necrostatin as a potential small molecule for the treatme
$240,750Serge E Przedborski · Columbia University Health Sciences · R21 · FY2011 · NS
Neuropathology Core
$240,696Dennis William Dickson · Mayo Clinic Rochester · P30 · FY2023 · AG
Exploring the role of AMP DEAMINASES in neuronal development and degeneration.
$240,667Naiara Akizu · Children'S Hosp Of Philadelphia · R00 · FY2019 · NS
Cerebrospinal fluid proteome mediated signaling in the developing CNS
$240,632Maria Lehtinen · Boston Children'S Hospital · R00 · FY2014 · NS
Reactive Microgliosis and Progressive Dopaminergic Neurotoxicity
$240,574Michelle L Block · Virginia Commonwealth University · R00 · FY2010 · ES
Introducing Mitochondrial Stasis in Neurons
$240,570Hiromi Sesaki · Johns Hopkins University · R21 · FY2014 · NS
Understanding the relationship between precocious neuronal differentiation and early-onset neurodegeneration
$240,495Chieh Chang · University Of Illinois At Chicago · R21 · FY2024 · AG
Gene Therapy for Alzheimer's Disease
$240,435Constance L Cepko · Harvard Medical School · R21 · FY2018 · AG
SUMO conjugation in cell biology and Development
$240,375Albert J Courey · University Of California Los Angeles · R01 · FY2007 · GM
Defining the role of NAD+ depletion in mitochondrial dysfunction of normal aging and neurodegeneration
$240,339Vilhelm A Bohr · National Institute On Aging · ZIA · FY2017 · AG
Administrative Core
$240,261Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2016 · AG
Plasma biomarkers of cerebral disease in X-linked adrenoleukodystrophy
$240,254Jaspreet Singh · Henry Ford Health System · R21 · FY2018 · NS
NEUROPATHOLOGY AND MECHANISMS IN PRECLINICAL AD
$240,207Juan Troncoso · Johns Hopkins University · P50 · FY2007 · AG